AI Mood Market: Stock Dashboard

Company: Annovis Bio Inc

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: NYSE

Index: -

P/E: -

EPS (ttm): -2.09

Insider Own: 14.86%

Shs Outstand: 26.11M

Perf Week: 18.14%

Market Cap: 62.93M

Forward P/E: -

EPS next Y: -1.22

Insider Trans: 38.23%

Shs Float: 22.23M

Perf Month: 43.45%

Enterprise Value: 45.80M

PEG: -

EPS next Q: -0.31

Inst Own: 10.86%

Short Float: 4.65%

Perf Quarter: -11.40%

Income: -30.26M

P/S: -

EPS this Y: 45.54%

Inst Trans: -2.49%

Short Ratio: 1.75

Perf Half Y: 42.60%

Sales: 0.00M

P/B: 2.56

EPS next Y Percentage: 3.20%

ROA: -228.37%

Short Interest: 1.03M

Perf YTD: -52.09%

Book/sh: 0.94

P/C: 3.67

EPS next 5Y: 21.65%

ROE: -365.03%

52W High: 7.80 -69.10%

Perf Year: -70.47%

Cash/sh: 0.66

P/FCF: -

EPS past 3/5Y: -6.68% -73.95%

ROIC: -165.08%

52W Low: 1.11 117.12%

Perf 3Y: -80.33%

Dividend Est.: -

EV/EBITDA: -

Sales past 3/5Y: - -

Gross Margin: -

Volatility W: 8.79%

Volatility M: 8.40%

Perf 5Y: -49.53%

Dividend TTM: -

EV/Sales: -

EPS Y/Y TTM: 54.85%

Oper. Margin: -

ATR (14): 0.18

Perf 10Y: -

Dividend Ex-Date: -

Quick Ratio: 7.65

Sales Y/Y TTM: -

Profit Margin: -

RSI (14): 62.96

Recom: 1.40

Dividend Gr. 3/5Y: - -

Current Ratio: 7.65

EPS Q/Q: 28.11%

SMA20: 16.34%

Beta: 1.62

Target Price: 13.75

Payout: -

Debt/Eq: 0.00

Sales Q/Q: -

SMA50: 12.61%

Rel Volume: 3.99

Prev Close: 2.11

Employees: 8

LT Debt/Eq: 0.00

Earnings: Nov 12 BMO

SMA200: 8.49%

Avg Volume: 588.74K

Price: 2.41

IPO: Jan 29, 2020

Option/Short: Yes / Yes

EPS/Sales Surpr.: -21.79% -

Trades:

Volume: 1,238,076

Change: 14.22%

AI Market Mood: Stock Dashboard

ANVS

Fundamental

Technical:

Latest News:

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral

ANVS AVXL LGVN

Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences ... somewhat bullish

ANVS GILD OMGA